N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide

C29H25FN6O3 — CID 156906612

IUPACN-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide
SMILESO=C(NCCc1cccc(F)c1)C(c1cccnc1)N(C(=O)c1cocn1)c1cn(Cc2ccccc2)cn1
InChIInChI=1S/C29H25FN6O3/c30-24-10-4-8-21(14-24)11-13-32-28(37)27(23-9-5-12-31-15-23)36(29(38)25-18-39-20-34-25)26-17-35(19-33-26)16-22-6-2-1-3-7-22/h1-10,12,14-15,17-20,27H,11,13,16H2,(H,32,37)
InChIKeyJTFZSOHLZFKYHF-UHFFFAOYSA-N
MW524.56 g/mol
LogP4.20
Rot. Bonds10

About N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide

N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide (PubChem CID 156906612) has the molecular formula C29H25FN6O3 and a molecular weight of 524.56 g/mol. Its IUPAC name is N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide.

Molecular Properties

Compound NameN-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide
PubChem CID156906612
Molecular FormulaC29H25FN6O3
Molecular Weight524.56 g/mol
Exact Mass524.20
IUPAC NameN-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide
SMILESO=C(NCCc1cccc(F)c1)C(c1cccnc1)N(C(=O)c1cocn1)c1cn(Cc2ccccc2)cn1
InChIInChI=1S/C29H25FN6O3/c30-24-10-4-8-21(14-24)11-13-32-28(37)27(23-9-5-12-31-15-23)36(29(38)25-18-39-20-34-25)26-17-35(19-33-26)16-22-6-2-1-3-7-22/h1-10,12,14-15,17-20,27H,11,13,16H2,(H,32,37)
InChIKeyJTFZSOHLZFKYHF-UHFFFAOYSA-N
XLogP4.20
TPSA106.15 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds10
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500524.56
LogP ≤ 54.20
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide?
The IUPAC name of N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide (CID 156906612) is N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide.
What is the SMILES notation for N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide?
The canonical SMILES for N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide is O=C(NCCc1cccc(F)c1)C(c1cccnc1)N(C(=O)c1cocn1)c1cn(Cc2ccccc2)cn1.
What is the InChIKey of N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide?
The InChIKey is JTFZSOHLZFKYHF-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H25FN6O3/c30-24-10-4-8-21(14-24)11-13-32-28(37)27(23-9-5-12-31-15-23)36(29(38)25-18-39-20-34-25)26-17-35(19-33-26)16-22-6-2-1-3-7-22/h1-10,12,14-15,17-20,27H,11,13,16H2,(H,32,37).
What are the key properties of N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide?
N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide has a molecular weight of 524.56 g/mol, XLogP of 4.20, 10 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-benzylimidazol-4-yl)-N-[2-[2-(3-fluorophenyl)ethylamino]-2-oxo-1-pyridin-3-ylethyl]-1,3-oxazole-4-carboxamide is sourced from PubChem (CID 156906612), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).